Terms: = Bone cancer AND CDH11, OB, 1009, ENSG00000140937, CAD11, P55287 AND Clinical Outcome
4 results:
1. Improving Risk Stratification for Pediatric Patients with Rhabdomyosarcoma by Molecular Detection of Disseminated Disease.
Lak NSM; Voormanns TL; Zappeij-Kannegieter L; van Zogchel LMJ; Fiocco M; van Noesel MM; Merks JHM; van der Schoot CE; Tytgat GAM; Stutterheim J
Clin Cancer Res; 2021 Oct; 27(20):5576-5585. PubMed ID: 34285060
[TBL] [Abstract] [Full Text] [Related]
2. European multicentre study on technical success and long-term clinical outcome of radiofrequency ablation for the treatment of spinal osteoid osteomas and osteoblastomas.
Beyer T; van Rijswijk CSP; Villagrán JM; Rehnitz C; Muto M; von Falck C; Gielen J; Thierfelder KM; Weber MA
Neuroradiology; 2019 Aug; 61(8):935-942. PubMed ID: 31161261
[TBL] [Abstract] [Full Text] [Related]
3. A 36-gene signature predicts clinical progression in a subgroup of ERG-positive prostate cancers.
Gasi Tandefelt D; Boormans JL; van der Korput HA; Jenster GW; Trapman J
Eur Urol; 2013 Dec; 64(6):941-50. PubMed ID: 23490727
[TBL] [Abstract] [Full Text] [Related]
4. Myeloablative chemotherapy with autologous peripheral blood stem cell transplantation for metastatic breast cancer: immunologic consequences affecting clinical outcome.
Chakraborty N; Bilgrami S; Maness L; Guo C; Perez-Diez A; Mukherji B; Tutschka P
Bone Marrow Transplant; 1999 Oct; 24(8):837-43. PubMed ID: 10516693
[TBL] [Abstract] [Full Text] [Related]
